
What comes next in Trump's legal battle over tariffs
WASHINGTON: A United States federal appeals court has temporarily halted a ruling that found many of President Donald Trump's tariffs illegal, but the chance it could ultimately back the original decision looms over the White House.
What is in the US Court of International Trade's original ruling, which the Trump administration is appealing, and what options does the administration have?
Which tariffs were affected?
The three-judge trade court ruled on Wednesday (May 28) that Trump overstepped his authority in imposing blanket tariffs by invoking emergency economic powers.
The judgment, although temporarily halted, affected levies unveiled on Apr 2, which involve a 10 per cent tariff on most trading partners and higher rates on dozens of economies, including China and the European Union. These higher levels are currently suspended while negotiations take place.
The ruling also applies to tariffs imposed on Canada, Mexico and China over their alleged roles in allowing an influx of drugs into the US.
But it left intact sector-specific levies like those on steel, aluminium and auto imports.
Why a pause?
The ruling by the little-known court, which has nationwide jurisdiction over tariff and trade disputes, initially gave the White House 10 days to complete the process of unwinding the levies.
But the US Court of Appeals for the Federal Circuit on Thursday granted a temporary stay "until further notice" while the Trump administration's appeals process plays out.
This means the tariffs can remain in effect for now, while a longer-term outcome is yet to be determined.
National Economic Council director Kevin Hassett told Fox News the administration is "very pleased with the ruling", dubbing it a victory.
What are Trump's alternatives?
The appeals court could eventually uphold the trade court's original decision to block Trump's sweeping tariffs.
The president, however, has other means to reinstate his tariff agenda, said Thibault Denamiel, a fellow at the Center for Strategic and International Studies.
These include Section 122 of the Trade Act of 1974, "which is intended to deal with a balance of payments emergency but does not require a formal investigation", Denamiel told AFP.
The authority restricts tariffs to 15 per cent, and they can only last 150 days.
But it is among the policy levers that Trump could pull as he seeks a "bridge" towards more lasting actions, said KPMG chief economist Diane Swonk.
Another option is Section 338 of the Trade Act of 1930, allowing the administration to impose tariffs of up to 50 per cent on countries that discriminate against the US, Denamiel said.
Does this affect trade talks?
The US trade court's ruling did not remove the threat of US tariffs for Europe or end the need for negotiations, said Andrew Kenningham, chief Europe economist at Capital Economics.
This is because the threat of reciprocal tariffs remains if the White House wins its appeal, he said.
Trump could also turn to sector-specific means as he did in his first term or seek congressional approval for tariffs, though this is less likely, Kenningham said.
It is not clear if negotiations will lose steam, Swonk added, given that the administration wants to leverage the threat of tariffs "very aggressively".
Even if the original ruling is eventually upheld, US officials could still buy time to exert pressure on other economies, including the EU and China.
What about the broader economy?
The court process "introduces greater ambiguity around the future direction of US trade policy", especially because the appeal is ongoing, said EY chief economist Gregory Daco.
"This legal development amplifies longer-lasting uncertainty for businesses navigating cross-border supply chains," he added in a note.
US stocks closed higher on Thursday, but economic fallout has already occurred in recent months with Trump's see-sawing approach to unveiling tariffs and pausing them selectively.
Financial markets have been roiled by policy shifts, and shipping halts due to high tariffs bring disruptions that cannot be cleared overnight, analysts said.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Times
an hour ago
- Business Times
Chinese firms warn EU procurement curb could hurt trade ties
[BEIJING] A Chinese business lobby group warned that EU actions to curb access of the country's medical device makers to government contracts in the bloc will hurt trade ties. The China Chamber of Commerce to the EU expressed 'profound disappointment' over the EU's use of a trade tool to limit Chinese companies' participation in public procurements, according to a Monday (Jun 2) statement from the Chinese group. 'Its targeted application against Chinese enterprises sends a troubling signal-not only adding new complexity to China-EU economic and trade relations, but also contradicting the EU's stated principles of openness, fairness, and non-discrimination in market access,' said the organisation, whose members include the Bank of China, Cosco Shipping Holdings and BYD. The dispute threatens to add another irritant to relations just as Beijing seeks to shore up ties with the EU, positioning itself as a more reliable partner as US President Donald Trump alienates the bloc over issues from tariffs to defence. Chinese Commerce Minister Wang Wentao is due to meet with EU trade officials early this month in Paris, where he may address the bloc's trade grievances including a lack of fair access to China's own procurement market. European leaders will travel to Beijing for a summit next month with their Chinese counterparts. The EU curb represented the first use of its International Procurement Instrument, a 2022 law that's meant to promote reciprocity in access to public procurement markets. It allows the EU's executive arm to impose various restrictions on firms seeking to participate in procurements, ranging from score adjustments in tenders to an outright ban from contracts. The EU launched an investigation into China's procurement of medical devices last April, with the probe finding in January that Beijing discriminated against foreign firms. Consultations failed to find alternative solutions, Bloomberg previously reported. The Chinese commerce chamber argued that market reciprocity must be based on 'an accurate understanding of historical and practical realities'. 'For years, European medical device companies have enjoyed significant access to the Chinese market, playing a key role in supporting the modernisation of China's healthcare system and achieving substantial growth,' it said. 'The EU's current decision fails to acknowledge this context and undermines the spirit of balanced engagement and mutual benefit.' BLOOMBERG


CNA
2 hours ago
- CNA
Asian markets rise as traders eye possible Trump-Xi talks
HONG KONG: Asian stocks rallied on Tuesday (Jun 3) as investors kept tabs on developments in the China-US trade war amid speculation the countries' leaders will hold talks soon. After a period of relative calm on the tariff front, Donald Trump at the weekend accused Beijing of violating last month's deal to slash huge tit-for-tat levies and threatened to double tolls on steel and aluminium. The moves jolted Asian markets on Monday, but hopes that the US president will speak with Chinese counterpart Xi Jinping - possibly this week - has given investors some hope for a positive outcome. Meanwhile, oil prices extended Monday's surge on a weak dollar and Ukraine's strike on Russian bombers parked deep inside the country that stoked geopolitical concerns as well as stuttering US-Iran nuclear talks. Trump has expressed confidence that a talk with Xi could ease trade tensions, even after his latest volley against the Asian superpower threatened their weeks-old tariff truce. "They violated a big part of the agreement we made," he said Friday. "But I'm sure that I'll speak to President Xi, and hopefully we'll work that out." It is unclear if Xi is keen on a conversation - the last known call between them was in the days before Trump's inauguration in January - but the US president's economic adviser Kevin Hassett signalled on Sunday that officials were anticipating something this week. US Treasury Secretary Scott Bessent - who last week warned negotiations with China were "a bit stalled" - said at the weekend the leaders could speak "very soon". Officials from both sides are set for talks on the sidelines of an Organisation for Economic Co-operation and Development (OECD) ministerial meeting in Paris on Wednesday. While there has been no movement on the issue, investors took the opportunity on Tuesday to pick up recently sold shares. Hong Kong gained more than 1 per cent while Shanghai returned from a long weekend on the front foot. There were also gains in Tokyo, Sydney, Wellington, Singapore, Taipei and Manila. DEALS QUEUED UP? The advances followed a positive day on Wall Street led by tech giants in the wake of a forecast-beating earnings report from chip titan Nvidia. Still, National Australia Bank's Rodrigo Catril remained nervous after Trump's latest salvos. "The lift in tariffs is creating another layer of uncertainty and tension," he wrote in a commentary. "European articles suggest the lift in tariffs doesn't bode well for negotiations with the region (and) UK steelmakers call Trump doubling tariffs 'another body blow'," he added. "The steel and aluminium tariffs also apply to Canada, so they will likely elicit some form of retaliation from there and while US-China trade negotiations are deteriorating due to rare earth, student visas and tech restrictions, steel tariffs will also affect China." Separately, US Commerce Secretary Howard Lutnick on Monday voiced optimism for a trade deal with India"in the not too distant future", adding that he was "very optimistic". And Japanese trade point man Ryosei Akazawa is eyeing another trip to Washington for more negotiations amid speculation of a deal as early as this month. Also in focus is Trump's signature "big, beautiful bill" that is headlined by tax cuts slated to add up to US$3 trillion to the nation's debt. Senators have started weeks of what is certain to be fierce debate over the mammoth policy package, which partially covers an extension of Trump's 2017 tax relief through budget cuts projected to strip health care from millions of low-income Americans. Oil prices extended Monday's surge that saw West Texas Intermediate briefly jump 5 per cent on concerns about an escalation of the Russia-Ukraine conflict and suggestions Washington could hit Moscow with stricter sanctions. That compounded news that the OPEC+ producers' grouping had agreed a smaller-than-expected increase in crude production. Traders were also monitoring tensions over Iran's nuclear programme after Tehran said it would not accept an agreement that deprives it of what it calls "peaceful activities".

Straits Times
2 hours ago
- Straits Times
Chinese firms warn EU procurement curb could hurt trade ties
The dispute threatens to add another irritant to relations between Beijing and the EU. PHOTO: REUTERS BEIJING – A Chinese business lobby group warned that EU actions to curb access of the country's medical device makers to government contracts in the bloc will hurt trade ties. The China Chamber of Commerce to the EU expressed 'profound disappointment' over the EU's use of a trade tool to limit Chinese companies' participation in public procurements, according to a statement from the Chinese group on June 2. 'Its targeted application against Chinese enterprises sends a troubling signal – not only adding new complexity to China-EU economic and trade relations, but also contradicting the EU's stated principles of openness, fairness, and non-discrimination in market access,' said the organisation, whose members include the Bank of China, Cosco Shipping Holdings and BYD. The dispute threatens to add another irritant to relations just as Beijing seeks to shore up ties with the EU, positioning itself as a more reliable partner as US President Donald Trump alienates the bloc over issues from tariffs to defence. Chinese Commerce Minister Wang Wentao is due to meet with EU trade officials early in June in Paris, where he may address the bloc's trade grievances, including a lack of fair access to China's own procurement market. European leaders will travel to Beijing for a summit in July with their Chinese counterparts. The EU curb represented the first use of its International Procurement Instrument, a 2022 law that's meant to promote reciprocity in access to public procurement markets. It allows the EU's executive arm to impose various restrictions on firms seeking to participate in procurements, ranging from score adjustments in tenders to an outright ban from contracts. The EU launched an investigation into China's procurement of medical devices in April 2024, with the probe finding in January that Beijing discriminated against foreign firms. Consultations failed to find alternative solutions, Bloomberg previously reported. The Chinese commerce chamber argued that market reciprocity must be based on 'an accurate understanding of historical and practical realities'. 'For years, European medical device companies have enjoyed significant access to the Chinese market, playing a key role in supporting the modernisation of China's healthcare system and achieving substantial growth,' it said. 'The EU's current decision fails to acknowledge this context and undermines the spirit of balanced engagement and mutual benefit.' BLOOMBERG Join ST's Telegram channel and get the latest breaking news delivered to you.